Head-to-head dispatch
Found vs Vaylen
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
The widest medication bench in the ranking — compounded, six brand-name products and oral orforglipron — priced off a membership rather than a sticker.
Marked down on: The $99/mo headline is a longer-plan floor — Found's own FAQ says the 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
Desk Score
The strongest all-rounder among the newer entrants — low pricing, brand access, oral routes, and all 50 states on one account.
Marked down on: Newer operator with a shorter track record
Vaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 81/100 (B−) for Found. Found still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Found
81/100
B−
Vaylen
91/100
A−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Found | Vaylen |
|---|---|---|
| Semaglutide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay | $179/mo |
| Tirzepatide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules | $239/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | People who want insurance run against their clinical visits and a clinician free to move them between compounded, brand-name and oral routes. | People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach. |
| Desk Score | 81/100B− | 91/100A− |
The verdict
Desk pick — VaylenVaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 81/100 (B−) for Found. Found still holds its ground where its strengths line up with yours.
Choose Found if…
People who want insurance run against their clinical visits and a clinician free to move them between compounded, brand-name and oral routes.
$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still precedes a ~$30 per-visit copay sema · $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules tirz · All 50 states
Choose Vaylen if…
People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach.
$179/mo sema · $239/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Found · Vaylen.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Found vs CoreAge Rx
- Vaylen vs Strut Health
- Found vs Ondra Health
- Vaylen vs Invigor Medical
- Found vs Vytora Health
- Vaylen vs Sesame Care
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.